The 497 members of the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics have been followed for mortality from 1975 to 1987. During this period 92 patients died. The most common cause of death was myocardial infarction: 36 (39.1%) deaths, heart disease was responsible for 51.1% of deaths and all cardiovascular disease for 55.4%. Neoplastic disease accounted for 25% of the deaths and diabetic nephropathy for 5.4%. Agestandardised mortality rates were higher in men than in women in both Type i (insulin-dependent) diabetes and Type 2 (non-insulin-dependent) diabetes. Standardised mortality ratios for the first and second five year follow-up periods were higher for men than for women in Type 2 diabetes but were higher for women than men in Type 1. The results suggest that the female survival advantage seen in the general population may persist in Type 2 but not in Type 1 diabetes.
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The excess mortality in men and women with diabetes from developed countries can be attributed in the main to an increased prevalence of vascular disease [1] and also to the occurrence of specific complications particularly diabetic nephropathy [2] . We report on the absolute and comparative rates and causes of deaths occurring over a 10-12 year follow-up of the 497 members of the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics (WHO Study).
The age range of the men and women recruited for the WHO study was 35-54 years; this was chosen to display the emergence of the vascular complications of diabetes without being unduly distorted by mortality from them. Recruitment was separate for either sex and was stratified in three groups across the age range. Any cohort of patients with diabetes is to an unknown extent a survivor population but the effect of diabetes-related mortality before 35 years of age is relatively small and is likely to be restricted to those with Type 1 (insulin-dependent) diabetes [3] . The duration of the diabetic state is known to be an important factor in the development of some of the complications of diabetes. Patient recruitment was therefore also stratified to represent a spectrum of duration of diabetes for each segment of the age range.
Subjects and methods
The London cohort of 35-54 year old men and women with diabetes, stratified as indicated by gender, age and duration was drawn by a randomised procedure from the diabetic out-patient clinics of King's College Hospital, Guy's Hospital and St Thomas's Hospital and was examined initially between 1975-1977 [4] . The inception cohort consisted of 254 men and 243 women. A diabetic subject was defined as a patient who had been diagnosed at least one year earlier and who was receiving treatment for diabetes at one of the participating centres at entry to the study. In this report Type i (insulin-dependent) diabetes is defined as those patients who started insulin treatment within one year of diagnosis and who continued on this treatment without break; using this definition 243 of the London patients were insulin-dependent and 254 had Type 2 (non-insulin-dependent) diabetes. The cohort broken down by age-range, sex and diabetes type is shown in Table 1 .
Mortality follow-up
All study participants were registered with the National Health Service Central Register which provided copies of death certificates as deaths have occurred. The survivors have recently been systematically re-studied thus positively identifying those still alive and leaving a small group (5%) whose fate is unknown. Where possible the information from the death certificates has been supplemented by [6] were used to calculate the death rates; age-adjusted mortality rates were calculated by the direct method and standardised mortality ratios (SMR) were calculated by the indirect method. 95% confidence intervals were calculated for the age adjusted rates according to Morris and Gardner [7] .
Statistical analys&

Results
Mortality experience except 250.3) was the underlying cause in four deaths; two were due to diabetic ketoacidosis and two from diabetic coma (unspecified). Table 4 shows the crude proportions of deaths due to cardiovascular and non-cardiovascular causes by gender in the two types of diabetes. Cardiovascular causes are responsible for a higher proportion of the deaths in patients with Type 2 diabetes than in patients with Type i diabetes.
The life-death status of the cohort up to 31 July 1987 is shown in Table 2 where the deaths are categorised by sex and diabetes type.
The most common underlying cause of death was myocardial infarction (ICD code 410) which accounted for 36 (39.1%) of all deaths ( 
Mortality rates
Age-adjusted death rates per 1000 person years during the period 1975-1987 are shown in Table 5 . The rates for all cause mortality for men were higher than those for women in each diabetes type but the difference was much more marked among patients with Type 2 diabetes than in those with Type i diabetes. The rates for cardiovascular mortality were lower for women in each diabetes type and among women were lower in those with Type 2 diabetes than those with Type 1 diabetes.
SMRs for the first two five year sequential follow-up periods have been calculated for each sex and diabetes type using the figures for the Greater London area as the standard population (Fig. 1) . The patterns are different within each diabetes type with female subjects having con- 3) (7.1-20.7) (3.9-12.9) (1.9-9.0) siderably higher SMRs in each 5 year period among patients with Type i diabetes and male subjects having higher SMRs in the patients with Type 2 diabetes.
Discussion
Cardiovascular disease is the principal cause of the excess and premature mortality seen among diabetic patients when compared to the general population. Arteriosclerotic disease was responsible for 75.6% of all deaths in the Joslin Clinic population between 1969 and 1979 [8] . A British study of deaths occurring in diabetic patients under 50 years of age found that vascular causes accounted for 41% of the deaths [9] . An analysis of death certificates mentioning diabetes in England and Wales for 1975 and 1976 found that the underlying cause category 'all circulatory diseases' was assigned to 51% of deaths in males and 52% of deaths in females [10] . These results are very similar to ours and confirm the importance of cardiovascular disease as a cause of death in this age-group of the diabetic population. The patients of the London WHO cohort were drawn from hospital clinic attenders and are therefore not as representative as a population sample would have been but are of value as most of the patients with diabetes in the age range studied would be attending a hospital clinic. Some authors have indicated that the female survival advantage seen in the general population is lost for diabetic women [3, 11] . In this group of British diabetic patients the age adjusted mortality rates are similar in men with either type of diabetes and are higher than those for the women. Age adjusted mortality rates from both all cause and cardiovascular mortality are higher among women with Type 1 diabetes than those with Type 2 diabetes. The SMRs show that women with Type 1 diabetes fare considerably worse than those with Type 2 diabetes, they also suggest that men with Type 2 diabetes in this age group have a greater excess mortality than men with Type 1 diabetes. Although our numbers are small these results would indicate that some of the female survival advantage may be retained in Type 2 diabetes. The results in Table 5 suggest that the low all cause mortality rate for women with Type 2 diabetes in this group is due to lower rates of death from both cardiovascular and non-cardiovascular causes. A recent population sample from the USA [12] (in which 80% of the patients were non-insulin treated) found no evidence of loss of female survival advantage whereas a long-term follow-up study of patients with Type i diabetes [13] found no difference in mortality between men and women. Kleinman et al. [12] have reviewed several North American studies and conclude that although four out of five previous studies did report a reduction of the 'female advantage' these were based on very small numbers. It therefore seems possible that the presence, or not, of a degree of female survival advantage in diabetes may be a function of the type of diabetes and not of the diabetic state itself. Our study would support other evidence that the female survival advantage seen in the general population may continue in Type 2 but not in Type 1 diabetes.
